X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (89670) 89670
Newspaper Article (8769) 8769
Publication (7848) 7848
Newsletter (7302) 7302
Book Review (841) 841
Book Chapter (612) 612
Magazine Article (459) 459
Trade Publication Article (225) 225
Dissertation (160) 160
Transcript (107) 107
Conference Proceeding (96) 96
Book / eBook (91) 91
Report (49) 49
Government Document (42) 42
Reference (42) 42
Web Resource (42) 42
Data Set (20) 20
Paper (5) 5
Journal / eJournal (3) 3
Presentation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (65797) 65797
male (40694) 40694
female (39493) 39493
index medicus (36083) 36083
hepatitis (32467) 32467
adult (32069) 32069
middle aged (31198) 31198
gastroenterology & hepatology (20262) 20262
hepatitis c (18467) 18467
hepatitis c virus (16752) 16752
aged (16083) 16083
health aspects (15356) 15356
hepatitis b (14579) 14579
liver (13381) 13381
infection (13114) 13114
risk factors (10837) 10837
infections (10538) 10538
interferon (10095) 10095
research (10053) 10053
adolescent (9674) 9674
hepatitis b virus (9422) 9422
antiviral agents - therapeutic use (9319) 9319
liver diseases (9294) 9294
infectious diseases (9078) 9078
virology (8942) 8942
prevalence (8731) 8731
animals (8592) 8592
immunology (8464) 8464
analysis (8404) 8404
care and treatment (7672) 7672
medical research (7622) 7622
genotype (7427) 7427
treatment outcome (7309) 7309
liver cirrhosis (7220) 7220
disease (7135) 7135
cirrhosis (7085) 7085
hepacivirus - genetics (7082) 7082
virus diseases (6563) 6563
viruses (6513) 6513
young adult (6225) 6225
patients (6159) 6159
hepatitis c, chronic - drug therapy (6069) 6069
liver cancer (5995) 5995
virus-infection (5881) 5881
liver - pathology (5864) 5864
therapy (5752) 5752
medicine, experimental (5736) 5736
hepatocellular-carcinoma (5572) 5572
epidemiology (5420) 5420
diagnosis (5333) 5333
medicine (5316) 5316
retrospective studies (5305) 5305
chronic disease (5175) 5175
alanine transaminase - blood (5137) 5137
child (5101) 5101
interferon-alpha - therapeutic use (5083) 5083
hepatocellular carcinoma (5011) 5011
hepatitis b virus - genetics (4890) 4890
fibrosis (4887) 4887
cancer (4845) 4845
biopsy (4802) 4802
gastroenterology and hepatology (4788) 4788
research article (4753) 4753
transplantation (4645) 4645
genetic aspects (4599) 4599
hiv (4554) 4554
prognosis (4396) 4396
digestive system diseases (4376) 4376
hepatology (4376) 4376
rna, viral - blood (4370) 4370
antiviral agents (4364) 4364
antigens (4342) 4342
viral load (4331) 4331
hcv (4304) 4304
oncology (4278) 4278
ribavirin (4190) 4190
mortality (4170) 4170
medicine, general & internal (4169) 4169
polymerase chain reaction (4115) 4115
studies (4111) 4111
drug therapy, combination (4071) 4071
drug therapy (4067) 4067
time factors (4058) 4058
medicine & public health (4046) 4046
hepatitis c, chronic - complications (4019) 4019
antibodies (3950) 3950
surgery (3909) 3909
hepatitis c - epidemiology (3886) 3886
mice (3885) 3885
risk (3884) 3884
expression (3843) 3843
hepatitis c - complications (3843) 3843
hepatitis-c virus (3813) 3813
prospective studies (3758) 3758
dna, viral - blood (3727) 3727
pharmacology & pharmacy (3718) 3718
chronic hepatitis-c (3716) 3716
biomarkers - blood (3674) 3674
biological response modifiers (3653) 3653
proteins (3647) 3647
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (63) 63
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Online Resources - Online (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (102250) 102250
Chinese (1095) 1095
Russian (798) 798
German (653) 653
French (528) 528
Spanish (468) 468
Japanese (423) 423
Korean (236) 236
Italian (222) 222
Polish (207) 207
Romanian (89) 89
Portuguese (87) 87
Hungarian (70) 70
Turkish (68) 68
Czech (47) 47
Croatian (36) 36
Ukrainian (23) 23
Arabic (20) 20
Danish (19) 19
Serbian (18) 18
Bulgarian (17) 17
Dutch (15) 15
Persian (14) 14
Swedish (9) 9
Norwegian (8) 8
Slovak (8) 8
Bosnian (4) 4
Hebrew (3) 3
Icelandic (3) 3
Urdu (3) 3
Slovenian (2) 2
Albanian (1) 1
Finnish (1) 1
Hindi (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 01/2011, Volume 121, Issue 1, pp. 308 - 317
Chronic infection with hepatitis C virus (HCV) is a major public health problem, with nearly 170 million infected individuals worldwide Current treatment for... 
MEDICINE, RESEARCH & EXPERIMENTAL | LIVER INFLAMMATION | GAMMA-INDUCIBLE PROTEIN-10 | VIRUS-INFECTION | DIPEPTIDYL-PEPTIDASE-IV | ANTIVIRAL THERAPY | INSULIN-RESISTANCE | IMMUNE-RESPONSES | CHRONIC HEPATITIS-C | LEVELS CORRELATE | PEGINTERFERON PLUS RIBAVIRIN | Chemokine CXCL10 - blood | Prognosis | Antiviral Agents - therapeutic use | Receptors, CXCR3 - blood | Humans | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Chemokine CXCL10 - antagonists & inhibitors | Dipeptidyl Peptidase 4 - blood | Hepatitis C, Chronic - virology | Hepatitis C, Chronic - therapy | Recombinant Proteins | Hepatitis C, Chronic - blood | Polyethylene Glycols - therapeutic use | T-Lymphocytes - virology | Treatment Failure | Hepatitis C, Chronic - immunology | Peptide Fragments - blood | Protein Array Analysis | T-Lymphocytes - immunology | Proteases | Physiological aspects | Research | Diagnosis | Hepatitis C | Drug therapy | Chemokines | Hepatitis C, Chronic/therapy | T-Lymphocytes/immunology | Polyethylene Glycols/therapeutic use | Dipeptidyl Peptidase 4/blood | Receptors, CXCR3/blood | Chemokine CXCL10/blood | T-Lymphocytes/virology | Hepatitis C, Chronic/blood | Interferon-alpha/therapeutic use | Chemokine CXCL10/antagonists & inhibitors | Life Sciences | Immunology | Antiviral Agents/therapeutic use | Hepatitis C, Chronic/immunology | Peptide Fragments/blood | Ribavirin/therapeutic use | Hepatitis C, Chronic/virology
Journal Article
Journal Article
Molecular Carcinogenesis, ISSN 0899-1987, 02/2011, Volume 50, Issue 2, pp. 136 - 142
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 04/2011, Volume 26, Issue 4, pp. 628 - 638
Chronic hepatitis B is a worldwide public health challenge. Knowledge of natural history of chronic hepatitis B is important for the management of the disease.... 
chronic hepatitis B | seroclearance of hepatitis B virus e antigen | hepatitis B virus DNA and hepatitis B surface antigen | viral load | liver disease progression | cirrhosis | hepatocellular carcinoma | Cirrhosis | Liver disease progression | Chronic hepatitis B | Hepatocellular carcinoma | Hepatitis B virus DNA and hepatitis B surface antigen | Viral load | Seroclearance of hepatitis B virus e antigen | VIRUS-INFECTION | TAIWAN | VACCINATION | FOLLOW-UP | RISK | LEVEL | LIVER-CIRRHOSIS | HEPATOCELLULAR-CARCINOMA | SURFACE-ANTIGEN | GASTROENTEROLOGY & HEPATOLOGY | Carcinoma, Hepatocellular - epidemiology | Prospective Studies | Humans | Middle Aged | Male | RNA, Viral - blood | Alanine Transaminase - blood | Hepatitis B, Chronic - diagnosis | Viral Load | alpha-Fetoproteins - analysis | Hepatitis B Surface Antigens - blood | Incidence | Liver Cirrhosis - epidemiology | Liver Neoplasms - blood | Liver Neoplasms - epidemiology | Time Factors | Hepatitis C Antibodies - blood | Adult | Female | Hepatitis B, Chronic - blood | Carcinoma, Hepatocellular - blood | Hepatitis B virus - immunology | Liver Neoplasms - virology | Liver Cirrhosis - diagnosis | Risk Assessment | Carcinoma, Hepatocellular - diagnosis | Hepatitis B, Chronic - epidemiology | Risk Factors | Carcinoma, Hepatocellular - virology | Liver Cirrhosis - blood | Biomarkers - blood | Disease Progression | Hepatitis B, Chronic - complications | Liver Cirrhosis - virology | Liver Neoplasms - diagnosis | Taiwan - epidemiology | Hepatitis B virus - genetics | Aged | Hepatitis B e Antigens - blood | Research Design | Liver cancer | Medical colleges | Antigens | National health insurance | Promoters (Genetics) | DNA | Development and progression | Hepatitis C | Hepatitis C virus | Public health | Smoking | Hepatitis B
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, p. e0133236
Serum levels of the interferon (IFN)-stimulated chemokine CXCL10 are increased during chronic HCV infection and associate with outcome of IFN-based therapy.... 
Recurrence | Interferons | Humans | Fluorenes - therapeutic use | Dipeptidyl Peptidase 4 - blood | Hepatitis C, Chronic - virology | Male | Adult | Female | Hepacivirus - physiology | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Hepacivirus - drug effects | Sofosbuvir - therapeutic use | Virus Replication - drug effects | Chemokine CXCL10 - blood | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Dipeptidyl Peptidase 4 - genetics | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Convalescence | Chemokine CXCL10 - genetics | Protein Processing, Post-Translational | Hepatitis C, Chronic - genetics | Viral Load - drug effects | VIRUS-INFECTION | CHEMOKINES | MULTIDISCIPLINARY SCIENCES | CHRONIC HEPATITIS-C | PROTEIN-10 | GENOTYPE 1 INFECTION | PREDICTIVE-VALUE | RIBAVIRIN | INDUCTION | ASSOCIATION | SPONTANEOUS CLEARANCE | Infection | Care and treatment | Analysis | Interferon | Biological response modifiers | Hepatitis C virus | Health aspects | Therapy | Laboratories | Chronic infection | Critical care | Amino acids | Infections | Ribavirin | Clinical outcomes | Proteins | Genotype & phenotype | Hepatitis | Immunology | Hepatology | Post-translation | Pretreatment | Drug dosages | Genotypes | Statistical analysis | Liver diseases | Dendritic cells | Serum levels | Studies | Infectious diseases | CXCL10 protein | Biomarkers | Chemokines | Virus Replication/drug effects | Viral Load/drug effects | Dipeptidyl Peptidase 4/blood | Dipeptidyl Peptidase 4/genetics | Chemokine CXCL10/blood | Hepatitis C, Chronic/blood | Life Sciences | Hepatitis C, Chronic/drug therapy | Hepatitis C, Chronic/virology | Hepatitis C, Chronic/genetics | Chemokine CXCL10/genetics | Benzimidazoles/therapeutic use | Hepacivirus/physiology | Fluorenes/therapeutic use | Antiviral Agents/therapeutic use | Sofosbuvir/therapeutic use | Hepacivirus/drug effects | Ribavirin/therapeutic use
Journal Article
Journal Article
Journal Article